Why City Therapeutics, Inc. (CTY) stock fell 13.3% on Wednesday, November 11, 2026
City Therapeutics, Inc. (CTY) closed at $17.01, down 13.30% on Wednesday, November 11, 2026, on volume of 458,676 shares (1.4× its 3-month average); market value about $900.0M, according to Nexqual market data (nexqual.com/moves/2026-11-11/CTY).
What happened: primary sources
Events Nexqual found for CTY on Wednesday, November 11, 2026 or the trading day before (November 10, 2026), each linked to its primary source:
- Nov 10, 2026: SEC 8-K: Regulation FD disclosure source
- Nov 10, 2026: Jefferies: Initiated, Buy, price target $32
- Nov 10, 2026: Oppenheimer: Initiated, Outperform, price target $46
- Nov 10, 2026: Goldman Sachs: Initiated, Early-Stage Biotech
- Nov 10, 2026: Stifel: Initiated, Buy, price target $34
These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.
More on CTY
CTY stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 11, 2026.
Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:53 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 18, 2026 at 20:53 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt